The role of the MicroBiome in PANCreatic cancer and its precursors— the study protocol of the MiBiPanc systematic review and meta-analysis

Abstract Background Pancreatic cancer is the third leading cause of cancer-related death in Northern America and fourth in Europe. Emerging evidence suggests that the pancreatic microbiome may play a significant role in the development and progression of this disease. Although the human microbiota c...

Full description

Saved in:
Bibliographic Details
Main Authors: My-Lan Pianka, Alexander Werba, Samuel Zimmermann, Johannes A. Vey, Eva Kalkum, Solveig Tenckoff, Andrew Tony-Odigie, Christoph W. Michalski, Frank Pianka
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Systematic Reviews
Subjects:
Online Access:https://doi.org/10.1186/s13643-025-02910-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849333633857355776
author My-Lan Pianka
Alexander Werba
Samuel Zimmermann
Johannes A. Vey
Eva Kalkum
Solveig Tenckoff
Andrew Tony-Odigie
Christoph W. Michalski
Frank Pianka
author_facet My-Lan Pianka
Alexander Werba
Samuel Zimmermann
Johannes A. Vey
Eva Kalkum
Solveig Tenckoff
Andrew Tony-Odigie
Christoph W. Michalski
Frank Pianka
author_sort My-Lan Pianka
collection DOAJ
description Abstract Background Pancreatic cancer is the third leading cause of cancer-related death in Northern America and fourth in Europe. Emerging evidence suggests that the pancreatic microbiome may play a significant role in the development and progression of this disease. Although the human microbiota contributes to health by supporting nutritional and hormonal homeostasis, modulating inflammation, detoxifying harmful compounds, and producing beneficial metabolites, several studies have implicated its crucial modulatory role in numerous diseases, including cancer. The main objective of this review is to investigate the specific relationship between the microbiome and pancreatic carcinogenesis. Methods A comprehensive literature search will identify studies examining the microbiome in human samples of saliva, pancreatic fluid, bile, pancreatic tissue, and feces of patients with chronic pancreatitis, precancerous pancreatic lesions, and pancreatic cancer. Studies differentiating bacteria to at least the genus level will be prioritized. Eligible studies include randomized controlled trials and observational studies analyzing the human microbiome in patients with chronic pancreatitis, pancreatic precursor lesions, or pancreatic cancer compared to healthy controls. Studies analyzing nonhuman samples, single bacterial strains, or lacking comparator groups will be excluded. The following databases will be searched without any restrictions to the publication date up until December 2024: the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (via PubMed), Embase, and Web of Science. Animal studies, case reports, and studies not reporting analyses of human samples are excluded. Details regarding blinding, risk of bias, and funding sources will be extracted and assessed. The main outcomes include the bacterial diversity in each sample type (stool, saliva, bile, intratumoral, and tissue) itemized for each diagnosis, identifying differentially abundant or depleted taxa, and evaluating the correlation of specific bacteria with disease prevention or progression and clinical outcomes. Data extraction will be performed independently by two reviewers. Risk-of-bias assessment will be performed using Cochrane tools appropriate for each study design. Comparisons will be analyzed by descriptive statistics, and meta-analyses will be performed when applicable. The review will be conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Discussion In summary, this systematic review aims to synthesize studies analyzing microbiome profiles in patients with chronic pancreatitis, precursor lesions, and pancreatic cancer, focusing on identifying bacterial diversity and specific taxa related to disease progression and development of cancer in comparison to healthy controls and will include a thorough critical appraisal of the available literature. Anticipated limitations include heterogeneity in microbiome sampling methods and potential variability in taxonomic resolution across studies. Systematic review registration PROSPERO CRD42023487995.
format Article
id doaj-art-51afca98f4d147ddaaa238edfc9e8a91
institution Kabale University
issn 2046-4053
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Systematic Reviews
spelling doaj-art-51afca98f4d147ddaaa238edfc9e8a912025-08-20T03:45:48ZengBMCSystematic Reviews2046-40532025-07-011411810.1186/s13643-025-02910-3The role of the MicroBiome in PANCreatic cancer and its precursors— the study protocol of the MiBiPanc systematic review and meta-analysisMy-Lan Pianka0Alexander Werba1Samuel Zimmermann2Johannes A. Vey3Eva Kalkum4Solveig Tenckoff5Andrew Tony-Odigie6Christoph W. Michalski7Frank Pianka8Department of Infectious Diseases, Medical Microbiology and Hygiene, Medical Faculty Heidelberg, Heidelberg UniversityStudy Center of the German Society of Surgery, University of HeidelbergInstitute of Medical Biometry, University of HeidelbergInstitute of Medical Biometry, University of HeidelbergStudy Center of the German Society of Surgery, University of HeidelbergStudy Center of the German Society of Surgery, University of HeidelbergDepartment of Infectious Diseases, Medical Microbiology and Hygiene, Medical Faculty Heidelberg, Heidelberg UniversityStudy Center of the German Society of Surgery, University of HeidelbergStudy Center of the German Society of Surgery, University of HeidelbergAbstract Background Pancreatic cancer is the third leading cause of cancer-related death in Northern America and fourth in Europe. Emerging evidence suggests that the pancreatic microbiome may play a significant role in the development and progression of this disease. Although the human microbiota contributes to health by supporting nutritional and hormonal homeostasis, modulating inflammation, detoxifying harmful compounds, and producing beneficial metabolites, several studies have implicated its crucial modulatory role in numerous diseases, including cancer. The main objective of this review is to investigate the specific relationship between the microbiome and pancreatic carcinogenesis. Methods A comprehensive literature search will identify studies examining the microbiome in human samples of saliva, pancreatic fluid, bile, pancreatic tissue, and feces of patients with chronic pancreatitis, precancerous pancreatic lesions, and pancreatic cancer. Studies differentiating bacteria to at least the genus level will be prioritized. Eligible studies include randomized controlled trials and observational studies analyzing the human microbiome in patients with chronic pancreatitis, pancreatic precursor lesions, or pancreatic cancer compared to healthy controls. Studies analyzing nonhuman samples, single bacterial strains, or lacking comparator groups will be excluded. The following databases will be searched without any restrictions to the publication date up until December 2024: the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (via PubMed), Embase, and Web of Science. Animal studies, case reports, and studies not reporting analyses of human samples are excluded. Details regarding blinding, risk of bias, and funding sources will be extracted and assessed. The main outcomes include the bacterial diversity in each sample type (stool, saliva, bile, intratumoral, and tissue) itemized for each diagnosis, identifying differentially abundant or depleted taxa, and evaluating the correlation of specific bacteria with disease prevention or progression and clinical outcomes. Data extraction will be performed independently by two reviewers. Risk-of-bias assessment will be performed using Cochrane tools appropriate for each study design. Comparisons will be analyzed by descriptive statistics, and meta-analyses will be performed when applicable. The review will be conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Discussion In summary, this systematic review aims to synthesize studies analyzing microbiome profiles in patients with chronic pancreatitis, precursor lesions, and pancreatic cancer, focusing on identifying bacterial diversity and specific taxa related to disease progression and development of cancer in comparison to healthy controls and will include a thorough critical appraisal of the available literature. Anticipated limitations include heterogeneity in microbiome sampling methods and potential variability in taxonomic resolution across studies. Systematic review registration PROSPERO CRD42023487995.https://doi.org/10.1186/s13643-025-02910-3Pancreatic cancerMicrobiomeGut microbiomeSystematic review
spellingShingle My-Lan Pianka
Alexander Werba
Samuel Zimmermann
Johannes A. Vey
Eva Kalkum
Solveig Tenckoff
Andrew Tony-Odigie
Christoph W. Michalski
Frank Pianka
The role of the MicroBiome in PANCreatic cancer and its precursors— the study protocol of the MiBiPanc systematic review and meta-analysis
Systematic Reviews
Pancreatic cancer
Microbiome
Gut microbiome
Systematic review
title The role of the MicroBiome in PANCreatic cancer and its precursors— the study protocol of the MiBiPanc systematic review and meta-analysis
title_full The role of the MicroBiome in PANCreatic cancer and its precursors— the study protocol of the MiBiPanc systematic review and meta-analysis
title_fullStr The role of the MicroBiome in PANCreatic cancer and its precursors— the study protocol of the MiBiPanc systematic review and meta-analysis
title_full_unstemmed The role of the MicroBiome in PANCreatic cancer and its precursors— the study protocol of the MiBiPanc systematic review and meta-analysis
title_short The role of the MicroBiome in PANCreatic cancer and its precursors— the study protocol of the MiBiPanc systematic review and meta-analysis
title_sort role of the microbiome in pancreatic cancer and its precursors the study protocol of the mibipanc systematic review and meta analysis
topic Pancreatic cancer
Microbiome
Gut microbiome
Systematic review
url https://doi.org/10.1186/s13643-025-02910-3
work_keys_str_mv AT mylanpianka theroleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT alexanderwerba theroleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT samuelzimmermann theroleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT johannesavey theroleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT evakalkum theroleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT solveigtenckoff theroleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT andrewtonyodigie theroleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT christophwmichalski theroleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT frankpianka theroleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT mylanpianka roleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT alexanderwerba roleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT samuelzimmermann roleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT johannesavey roleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT evakalkum roleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT solveigtenckoff roleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT andrewtonyodigie roleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT christophwmichalski roleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis
AT frankpianka roleofthemicrobiomeinpancreaticcanceranditsprecursorsthestudyprotocolofthemibipancsystematicreviewandmetaanalysis